CRVS
Corvus Pharmaceuticals, Inc.stockNASDAQ
Market OpenNov 19, 2026 3:12:21 PM EST
10.05USD-1.374%(-0.14)439,727
Pre-marketNov 19, 2026 8:38:30 AM EST
10.15USD-0.393%(-0.04)
CRVS Financials
In Q3 FY 2026 (ended ), Corvus Pharmaceuticals, Inc. (CRVS) reported net income of −$20.34M, operating cash flow of −$12.22M, and assets of $223.88M (filed ).
Loading financial statements…